Increased Adenosine A1 Receptor Levels in Hemianopia Patients after Cerebral Injury: An Application of PET Using 11C-8- Dicyclopropylmethyl-1-Methyl-3-Propylxanthine

Clinical Nuclear Medicine

Volumn 37, Issue 12, 2012, Pages 1146-1151

  Suzuki, Yukihisa ^a,c   Nariai, Tadashi ^b,c   Kiyosawa, Motohiro ^a,c   Mochizuki, Manabu ^a   Kimura, Yuichi ^c,d   Oda, Keiichi ^c   Ishii, Kenji ^c   Ishiwata, Kiich ^c  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

^d NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

Author keywords

adenosine A1 receptor; homonymous hemianopia; neurorepair mechanisms; positron emission tomography; primary visual cortex; visual field

Indexed keywords

8 DICYCLOPROPYLMETHYL 1 METHYL 3 PROPYLXANTHINE C 11; 8 DICYCLOPROPYLMETHYL 1,3 DIPROPYLXANTHINE; ADENOSINE A1 RECEPTOR; BENZODIAZEPINE RECEPTOR; CARBON 11; FLUMAZENIL C 11; FLUORODEOXYGLUCOSE F 18; UNCLASSIFIED DRUG; 1 METHYL 8 DICYCLOPROPYLMETHYL 1 METHYL 3 PROPYLXANTHINE; 1-METHYL-8-DICYCLOPROPYLMETHYL-1-METHYL-3-PROPYLXANTHINE; DIAGNOSTIC AGENT; FLUMAZENIL; GLUCOSE; XANTHINE DERIVATIVE;

ADULT; AGED; ARTICLE; BRAIN INJURY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIFFUSION WEIGHTED IMAGING; DRUG BINDING; FEMALE; GLUCOSE BRAIN LEVEL; GLUCOSE METABOLISM; GOLDMANN APPLANATION TONOMETER; HOMONYMOUS HEMIANOPIA; HUMAN; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; POSITRON EMISSION TOMOGRAPHY; STRIATE CORTEX; VISUAL FIELD; HEMIANOPIA; METABOLISM; MIDDLE AGED; PROGNOSIS; SCINTISCANNING;

ADULT; AGED; BRAIN INJURIES; FEMALE; FLUMAZENIL; GLUCOSE; HEMIANOPSIA; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RECEPTOR, ADENOSINE A1; XANTHINES;

EID: 84870195484     PISSN: 03639762     EISSN: 15360229     Source Type: Journal    
DOI: 10.1097/RLU.0b013e31826392a7     Document Type: Article

References (37)

1. Ishiwata K, Shimada J, Ishii K, et al. Assessment of adenosine A2A receptors with PET as a new diagnostic tool for neurological disorders. Drugs Future. 2002;27:569-576.
2. Ishiwata K, Kimura Y, de Vries EFJ, et al. PET tracers for mapping adenosine receptors as probes for diagnosis of CNS disorders. Cent Nerv Syst Agents Med Chem. 2007;7:57-77.
3. Bauer A, Ishiwata K. Adenosine receptor ligands and PET imaging of the CNS. Handb Exp Pharmacol. 2009;193:617-642.
4. Ishiwata K, Kimura Y, Oda K, et al. Development of PET radiopharmaceuticals and their clinical applications at the Positron Medical Center. Geriatr Gerontol Int. 2010;10(suppl 1):S180YS196.
5. Fukumitsu N, Ishii K, Kimura Y, et al. Adenosine A1 receptors using 8-dicyclopropylmethyl-1-[11C]-methyl-3-propylxanthine PET in Alzheimer's disease. Ann Nucl Med. 2008;22:841-847.
6. Mishina M, Ishiwata K, Naganawa M, et al. Adenosine A2A receptors measured with [11C]TMSX PET in the striata of Parkinson's disease patients. PLoS ONE. 2011;6:e17338.
7. Nariai T, Shimada Y, Ishiwata K, et al. PET imaging of adenosine A1 receptors with 11C-MPDX as an indicator of severe cerebral ischemic insult. J Nucl Med. 2003;44:1839-1844.
8. Kiyosawa M, Ishiwata K, Noguchi J, et al. Neuroreceptor bindings and synaptic activity in visual system of monocularly enucleated rat. Jpn J Ophthalmol. 2001; 45:264-269.
9. Wang WF, Ishiwata K, Kiyosawa M, et al. Adenosine A1 and benzodiazepine receptors and glucose metabolism in the visual structures of rats monocularly deprivated by enucleation or eyelid suture at a sensitive period. Jpn J Ophthalmol. 2003;47:182-190.
10. Suzuki Y, Kiyosawa M, Mochizuki M, et al. Cortical blindness following aortic arch surgery. Jpn J Ophthalmol. 2001;45:547-549.
11. Bosley TM, Dann R, Silver FL, et al. Recovery of vision after ischemic lesions: positron emission tomography. Ann Neurol. 1987;21:444-450.
12. Heiss WD, Sobesky J, Smekal U, et al. Probability of cortical infarction predicted by flumazenil binding and diffusion-weighted imaging signal intensity: a comparative positron emission tomography/magnetic resonance imaging study in early ischemic stroke. Stroke. 2004;35:1892-1898.
13. Heiss WD, Kracht L, Grond M, et al. Early [11C]-flumazenil/H2O positron emission tomography predicts irreversible ischemic cortical damage in stroke patients receiving acute thrombolytic therapy. Stroke. 2000;31:366-369.
14. Mishina M, Senda M, Kimura Y, et al. Intrasubject correlation between static scan and distribution volume images for [11C]flumazenil PET. Ann Nucl Med. 2000;14:193-198.
15. Kimura Y, Ishii K, Fukumitsu N, et al. Quantitative analysis of adenosine A1 receptors in human brain using positron emission tomography and [1-methyl-11C]8-dicyclopropylmethyl-1-methyl-3-propylxanthine. Nucl Med Biol. 2004;31: 975-981.
16. Logan J, Fowler JS, Volkow ND, et al. Graphical analysis of reversible radioligand binding fromtimeYactivitymeasurements applied to [N-11C-methyl]-(j)-cocaine PET studies in human subjects. J Cereb Blood Flow Metab. 1990;10: 740-747.
17. Ardekani BA, Braun M. A fully automatic multimodality image registration algorithm. J Comput Assist Tomogr. 1995;19:615-623.
18. Suzuki Y, Horie C, Kiyosawa M, et al. Measurement of 11C-flumazenil binding in the visual cortex predicts the prognosis of hemianopia. J Neurol Sci. 2008; 268:102-107.
19. Meyer PT, Elmenhorst D, Boy C, et al. Effect of aging on cerebral A1 adenosine receptors: a [18F]CPFPX PET study in humans. Neurobiol Aging. 2007;28: 1914-1924.
20. Suhara T, Inoue O, Kobayashi K, et al. No age-related changes in human benzodiazepine receptor binding measured by PET with [11C]Ro 15-4513. Neurosci Lett. 1993;159:207-210.
21. Zezula J, Cortés R, Probst A, et al. Benzodiazepine receptor sites in the human brain: autoradiographic mapping. Neuroscience. 1988;25:771-795.
22. Fujimoto T, Matsumoto T, Fujita S, et al. Changes in glucose metabolism due to aging and gender-related differences in the healthy human brain. Psychiatry Res. 2008;164:58-72.
23. Kawachi T, Ishii K, Sakamoto S, et al. Gender differences in cerebral glucose metabolism: a PET study. J Neurol Sci. 2002;199:79-83.
24. Hagberg H, Anderson P, Lacarewicz J, et al. Extracellular adenosine, inosine, hypoxanthine, and xanthine in relation to tissue nucleotides and purines in rat striatum during transient ischemia. J Neurochem. 1987;49:227-231.
25. Mayfield RD, Jones BA, Miller HA, et al. Modulation of endogenous GABA release by an antagonistic adenosine A1/dopamine D1 receptor interaction in rat brain limbic regions but not basal ganglia. Synapse. 1999;33:274-281.
26. Jeong HJ, Jang IS, Nabekura J, et al. Adenosine A1 receptor-mediated presynaptic inhibition of GABAergic transmission in immature rat hippocampal CA1 neurons. J Neurophysiol. 2003;89:1214-1222.
27. Lai DM, Tu YK, Liu IM, et al. Increase of adenosine A1 receptor gene expression in cerebral ischemia of Wistar rats. Neurosci Lett. 2005;387:59-61.
28. Siniscalchi A, Rodi D, Gessi S, et al. Early changes in adenosine A1 receptors in cerebral cortex slices submitted to in vitro ischemia. Neurochem Int. 1999;34: 517-522.
29. Ishiwata K, Nariai T, Kimura Y, et al. Preclinical studies on [11C]MPDX for mapping adenosine A1 receptors by positron emission tomography. Ann Nucl Med. 2002;16:377-382.
30. Logan M, Sweeney MI. Adenosine A1 receptor activation preferentially protects cultured cerebellar neurons versus astrocytes against hypoxia-induced death. Mol Chem Neuropathol. 1997;31:119-133.
31. Von Lubitz DK, Lin RC, Paul LA, et al. Postischemic administration of adenosine amine congener (ADAC): analysis of recovery in gerbils. Eur J Pharmacol. 1996;316:171-179.
32. Phillis JW, Smith-Barbour M, O'Regan MH, et al. Amino acid and purine release in rat brain following temporary middle cerebral artery occlusion. Neurochem Res. 1994;19:1125-1130.
33. Andine P. Involvement of adenosine in ischemic and postischemic calcium regulation. Mol Chem Neuropathol. 1993;18:35-49.
34. Xu XH, Zhang SM, Yan WM, et al. Development of cerebral infarction, apoptotic cell death and expression of X-chromosome-linked inhibitor of apoptosis protein following focal cerebral ischemia in rats. Life Sci. 2006;78: 704-712.
35. D'Alimonte I, Ballerini P, Nargi E, et al. Staurosporine-induced apoptosis in astrocytes is prevented by A1 adenosine receptor activation. Neurosci Lett. 2007;418:66-71.
36. Ngai AC, Coyne EF, Meno JR, et al. Receptor subtypes mediating adenosineinduced dilation of cerebral arterioles. Am J Physiol Heart Circ Physiol. 2001; 280:H2329YH2335.
37. Zhou AM, Li WB, Li QJ, et al. A short cerebral ischemic preconditioning upregulates adenosine receptors in the hippocampal CA1 region of rats. Neurosci Res. 2004;48:397-404.